Physician profile
William Warden
NPI 1831178599
$1,758.79
in general payments reported to CMS, 2019-2025
11 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $317 · 2021: $222 · 2022: $15.85 · 2023: $180 · 2024: $190 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $488.76 | 2019-2025 | Mako |
| Horizon Therapeutics Plc | $435.38 | 2019-2021 | |
| Pacira Therapeutics, INC. | $308.34 | 2020-2021 | |
| Miach Orthopaedics, INC. | $228.60 | 2023-2024 | |
| Atricure, INC. | $75.70 | 2024 | |
| Depuy Synthes Sales INC. | $70.20 | 2019-2023 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $61.68 | 2023-2025 | Zilretta, Iovera |
| Saxum Surgical, INC. | $26.96 | 2025 | |
| Linvatec Corporation | $23.62 | 2019 | |
| Bioventus LLC | $23.02 | 2025 | Xcell |
| Zimmer Biomet Holdings, INC. | $16.53 | 2023 | Juggerknotless Soft Anchor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Warden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.